PRDX5 and non-small cell lung carcinoma: Non-small cell lung cancer (NSCLC) is associated with increased plasma levels of thioredoxin reductase and higher expression of this protein in the tumor, which in this case does not only serve as a biomarker, but also as a possible differential diagnostic criterion in lung cancer [129].